Report #2831796

Overview

Sex

Female

Age

Age unknown

State

NJ

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

A dose of Kinrix was administered to a 20 weeks old female patient.; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 20-week-old female patient who received DTPa-IPV (Kinrix) (batch number 5H95B, expiry date 16-FEB-2026) for prophylaxis. Previously administered products included Pediarix (received doses on an unknown date). On an unknown date, the patient received Kinrix. On an unknown date, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: A dose of Kinrix was administered to a 20 weeks old female patient.). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 11-MAR-2025 The health care professional reported that they administered a dose of Kinrix to a 20 weeks old female patient for their 2nd dose of DTaP and IPV, which led to inappropriate age at vaccine administration. The patient had previous doses of Pediarix. The reporter was ask was this a mistake or would it be a problem for the baby.